Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.

Abstract

As HIV disease is treated earlier with more efficacious drugs, survival and thus costs of care will continue to increase.

The availability in high-income countries of widely used antiretroviral drugs in generic form could reduce these costs.

Full Text

DOI - AIDS (London, England) (DOI)
Swets Information Services - full-text online
Ovid Technologies, Inc. - full-text online

Subjects

Similar articles

Pediatric HIV costs across three treatment eras from 1986 to 2007. (2010-09-02)
New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom. (2012-07-12)
Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection. (2012-05-18)
Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care. (2006-10-20)
[The pharmacoeconomics of antiretroviral drugs and the role of adherence]. (2013-01-09)
What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria? (2012-07-24)
Net financial benefits of averting HIV infections among people who inject drugs in Urumqi, Xinjiang, Peoples Republic of China (2005-2010). (2012-07-29)
HIV treatment and care in resource-constrained environments: challenges for the next decade. (2012-08-22)
Estimating the cost to rural ambulating HIV/AIDS patients on highly active antiretroviral therapy (HAART) in rural Ghana: a pilot study. (2012-06-04)

Authors

Publication date

2011-11-30

Journal

AIDS
AIDS (1473-5571)

Journal topics

Language

Eng.

Copyright

AIDS (London, England)

ATIP-Avenir Inserm U, Université de Lille Nord de France, France.

Release reference

AIDS. 2012 Jan;26(1):45-56

Related books

Español | English

© Galenicom 1999-2013